Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021

SELL
$55.56 - $60.79 $747,726 - $818,111
-13,458 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$48.42 - $60.18 $1.56 Million - $1.94 Million
-32,317 Reduced 70.6%
13,458 $806,000
Q1 2021

May 06, 2021

BUY
$47.16 - $54.44 $1.01 Million - $1.17 Million
21,436 Added 88.07%
45,775 $2.28 Million
Q4 2020

Feb 09, 2021

BUY
$48.52 - $58.02 $1.18 Million - $1.41 Million
24,339 New
24,339 $1.22 Million
Q3 2020

Nov 09, 2020

SELL
$53.07 - $61.1 $2.35 Million - $2.71 Million
-44,304 Closed
0 $0
Q2 2020

Aug 04, 2020

BUY
$43.1 - $55.31 $1.21 Million - $1.55 Million
28,103 Added 173.46%
44,304 $2.34 Million
Q1 2020

May 06, 2020

BUY
$37.79 - $51.33 $163,479 - $222,053
4,326 Added 36.43%
16,201 $724,000
Q4 2019

Feb 11, 2020

SELL
$42.46 - $50.46 $1.13 Million - $1.34 Million
-26,507 Reduced 69.06%
11,875 $592,000
Q3 2019

Nov 07, 2019

SELL
$40.12 - $45.47 $914,535 - $1.04 Million
-22,795 Reduced 37.26%
38,382 $1.71 Million
Q2 2019

Jul 25, 2019

BUY
$37.28 - $41.68 $1.99 Million - $2.23 Million
53,394 Added 686.03%
61,177 $2.53 Million
Q1 2019

Apr 15, 2019

BUY
$35.49 - $43.02 $276,218 - $334,824
7,783 New
7,783 $315,000
Q4 2018

Feb 12, 2019

SELL
$36.86 - $41.49 $675,127 - $759,930
-18,316 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$34.76 - $39.72 $1.05 Million - $1.2 Million
-30,309 Reduced 62.33%
18,316 $725,000
Q2 2018

Aug 07, 2018

BUY
$34.55 - $37.05 $207,196 - $222,188
5,997 Added 14.07%
48,625 $1.71 Million
Q1 2018

May 04, 2018

SELL
$32.97 - $36.63 $262,507 - $291,648
-7,962 Reduced 15.74%
42,628 $1.49 Million
Q4 2017

Feb 01, 2018

SELL
$32.09 - $34.78 $110,935 - $120,234
-3,457 Reduced 6.4%
50,590 $1.76 Million
Q3 2017

Oct 18, 2017

BUY
$28.96 - $34.0 $1.57 Million - $1.84 Million
54,047
54,047 $1.83 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $247B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.